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had 92.9%, 93.2%, 83.9% and 93.5% resistance. 
The 4th generation Cephalosporin, Cefepime had 
78.7% resistance. Acinetobacter showed complete 
resistance against all the generations of 
cephalosporins. Maximum sensitivity (40%) 
was shown by Escherichia Coli against 
Cefepime Patterns of resistance shown  
gainst Ceftazidime, Ceftriaxone and Cefepime showed 
association with the type of bacteria, P-values 0.020, 
0.002 and 0.026 respectively.                          
Conclusion:   Cephalosporins   have   started    to 
lose their efficacy in the treatment of  commonly 
isolated  bacteria  in  hospitals.  Cefepime   may   still  
be  used  to  treat  Urinary  tract   infections,   rest   of 
the cephalosporins have become resistant. 
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Introduction 
Antimicrobial  resistance  has  been   termed   as   one  
of  the  greatest  threats  to  health  on  a   global   scale 
in  this  decade.1  The   indiscriminate   use   of 
antibiotics  in  order  to  treat  diseases   among   
humans and animals has unfortunately led to an 
increase of antimicrobial resistance, mainly by 
encouraging  bacteria  to  adapt  new   ways   to   
sustain life.2  Antimicrobial  resistance  reportedly 
claims over 700,000 lives globally each year.3 The 
situation at  hand  has  led  to  clinicians  running  out  
of  therapeutic  options  for  treating  diseases.4  
Bacterias   mainly   attain   resistance   against 
antibiotics  by  mutations,  expression  of   efflux 
pumps, formation of enzymes  and  protection  of  
target sites.5 Increasing resistance has found to be  
linked to the overuse and misuse of these drugs. 
Abstract 
Background:  Antimicrobial resistance is increasing 
dramatically with the passage of time due to an 
indiscriminate use and prescription of antibiotics in 
Pakistan. It is therefore necessary to conduct studies 
identifying resistance and sensitivity patterns time and 
again so infections can be treated appropriately. Hence, 
to determine the efficacy of Cephalosporins against 
pathogens isolated in Holy Family Hospital we 
conducted this study.   
Materials and Methods: In this cross 
sectional study 382 culture positive samples were 
studied. Bacteria which are recommended to be tested 
against Cephalosporins as per Clinical & Laboratory 
Standard Institute were included in the study. Several 
samples were collected from the OPD and wards of the 
hospital. The specimen were stored at appropriate 
temperature and analyzed in the laboratory to 
determine the presence of different pathogens by use of 
microbiological and biochemical tests. Antibiotic 
resistance was determined using the disc diffusion 
method. Previous records were also included in the 
study. The data was entered and analyzed using SPSS 
version 23. Pearson’s chi square test was used to 
identify.    
Results: Out of the 382 positive culture 
samples, the most common bacteria to be 
isolated was Escherichia Coli, followed by 
Acinetobacter, Klebsiella Pneumonae, 
Pseudomonas, Coliforms, Proteus, Enterococci 
and Providencia. Cephradine had 100% 
resistance against Enterococcus. While 3rd 
generation Cephalosporins, Cefixime, 
Cefotaxime, Ceftazidime and Ceftraixone 
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In case of Cephalosporins, Extended Spectrum Beta-
lactamases and AmpC beta-lactamases are responsible 
for triggering resistance.6 
 
Cephalosporins are B-lactam structure containing 
antibiotics,  making  them   similar   to   penicillin 
except  that  they  also  inhibit   transpeptidation 
reaction  during  peptidoglycan  synthesis.7   These 
drugs are widely used to treat infections such as 
pyelonephritis, pneumonia, gonorrhea, 
meningitis,  urinary   tract   infections,   bacteremia,   
and septic shock 8; and also as prophylaxis in 
postoperative and preoperative interventions.9 
Cephalosporins; even though accepted as broad 
spectrum,   their   activity    against    bacteria 
commonly isolated in hospitals is  highly  
questionable.10 Moreover,  association  between over-
use   and   increased   incidence   of   resistance  has 
been proved  by  many  studies,  specifically  in  case of 
this class of drug.11-13 
 
According to previously conducted studies, 
Cephalosporins   are   majorly   threatened   by   a   set 
of  pathogens  which  confer   high   rates   of   
resistance. These mainly include  Enterococcus  
faecium,  Staphylococcus  aureus,   Clostridium  
difficile, Klebsiella pneumoniae, Acinetobacter 
baumanii, Pseudomonas aeruginosa, and 
Enterobacteriaceae (ESCKAPE).14 
 
The  situation  in  Pakistan,  in   particular,   is   dire   
due  to  the  overuse  of   drugs   and   over   
prescription   of   cephalosporins    and    penicillins.  
The increased resistance owes to  the  under-  
developed laboratories  in  many  areas  where 
extended  spectrum  beta  lactamase  (ESBL)  are  
usually   not   tested.15   Hence,   studies   determining 
the  new  trends  of  antibiotic  resistance  and 
sensitivity  must  be   conducted   so   that   recent 
trends and patterns can be identified. This would 
eventually help in improving the therapeutic 
interventions  that  clinicians  make  in  their  day  to 
day practice. 
 
Materials and Methods: 
This cross-sectional study was conducted over a period 
of 6 months, from December 2017 to June 2018 at the 
Microbiology Department of Holy Family Hospital, 
Rawalpindi. The study population was those patients 
who had culture positive results for bacteria on which 
susceptibility testing by Cephalosporins was 
recommended according to Clinical and Standard 
Laboratory Institute. 17 
 
Using   expected   proportion   of   overall    sensitivity 
of the drugs, to the isolated bacteria, as 
Cephadrine (41.14%), Ceftazidime (56.60%), 
Cefotaxime (56.89%), Ceftriaxone (54.66%), 
Cefixime (15.18%) and Cefipime (63.72%) from 
reference   study16,   and   taking   a   confidence   level 
of  95%,  absolute  precision  5%,   the   minimum 
sample size calculated was  382.  Permission  was 
sought from Ethical Committee of Institutional 
Research Forum, Rawalpindi Medical University, 
Rawalpindi.  Simple  random  sampling   was   done 
and previous records were included as well. 
 
The biological samples which  were  included  as  a  
part  of  investigation  majorly   included   urine, 
wound, pus, endotracheal tube sample, tracheal 
secretions,   sputum,   Foley’s   tip,   high    vaginal  
swab and miscellaneous. The samples  were  taken  
from patients presenting to OPD and  also  from 
patients  admitted  in   IPD   of   Holy   Family  
Hospital. They were then  transferred  to  the  
laboratory   and   stored    at    appropriate   
temperature. Only samples with positive culture  
results  were  included   in   the   study.   Bacteria’s  
were  identified  after  biochemical   and  
microbiological   testing.   Repeated   samples    from 
the same patient and mishandled specimen were 
excluded from the study. 
In order  to  test  for  Antimicrobial  susceptibility, 
Kirby  Bauer  Disc  Diffusion  method  was   implied 
and  Muller  Hilton  Agar  Plates  were  used  as  per  
the recommendation of Clinical and Laboratory 
Standards Institute.17 After the culture positive 
inoculums  had  dried,  antibiotics   discs   were   
applied 2  cm  apart  on  the  plates  inoculated  with  
the  sample.  The  plates   were   incubated   overnight  
at 37 degree Celsius and then checked  for  
susceptibility according to the break points 
recommended  by   the   manufacturer   following   
CLSI standards. 
 
The   antibiotics   used   in   testing   spanned   over 
three  generations  of  Cephalosporins;   1st,   3rd   and   
4th.  The  selection  of  antibiotics  was  made   
depending on the type of bacteria isolated and 
corresponding guidelines for testing. Moreover, 
alternate Cephalosporins were used on basis of 
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their  availability.  The  Cephalosporins  used  for 
testing and their generations are given below: 
i) Cephradine (1st Generation) 
ii) Cefixime (3rd Generation) 
iii) Cefotaxime (3rd Generation) 
iv) Ceftazidime (3rd Generation) 
v) Ceftriaxone (3rd Generation) 
vi) Cefepime (4th Generation) 
Frequencies    and    percentages    were    determined 
for specimen  types,  ward,  bacteria  and  resistance 
and sensitivity patterns for  each  antibiotic.  Chi- 
square test was used as  a  test  of  significance;  p-  
value  of  <0.05  was  considered  statistically 
significant. 
Among  the  culture  positive  382   samples,  
Escherichia   Coli    was    commonest    isolated  
bacteria (24.9%), while the second most common 
pathogen was Acineobacter (24.3%). (Table I) 
 
The   first   generation   Cephalosporin   Cephradine 
was tested against Enterococcus as per  CLSI  
guidelines. All the 13 culture positive 
enterococcus were found to  be  resistant  to 
Cephradine, 100% resistance (Table II). 
 
Results 
The  subjects  that   were   included   in   the   study 
were of  both  genders,  out  of  382  subjects  219 
(57.3%)  were  males   and   163   (42.7%)   were   
females. Out of the 382 samples, majority of the  
samples were collected from OPD accounting for 
134  (35.1%).  55  (14.3%)  samples  were   collected   
from Medical ICU, 53 (13.9%) from Burn Unit, 35  
(9.2%) from Surgical ICU, 19 (5.0%) from Medical  
Units,  32  (8.4%)  from  Surgical  Units,  15  (3.9%)   
from  NPB.  The   remaining   40   (10.4%)   samples 
were taken from Gynecology ward (11), 
Gastroenterology Ward (8), Pediatrics ICU (7), 
Pediatrics Ward (4), Department  of  Infectious  
Diseases  (2),  ENT  (4),  CCU  (1),   Emergency   (1)   
and Nephrology (2). 
Among  the  samples,  most  inoculates  were   from  
Pus (n=102), followed by Wounds (n=91),  Urine  
(n=60), ETT  (n=28),  Tracheal  Secretion  (n=27),  
Foley’s  TIP   (n=20)   and   Vaginal   Swabs   (n=17). 
Rest  of  the  37   samples   were   from   Sputum, 
Central Venous Line, Bronchial  secretion,  pleural  
fluid, drains, bile etc. 
 
Table I: Frequency of Isolated Bacteria 
 
Bacteria Frequency Percent 
ACINETOBACTER 93 24.3% 
COLIFORMS 46 12.0% 
E. COLI 95 24.9% 
ENTEROCOCCUS 17 4.5% 
KLEBSIELLA 56 14.7% 
PROTEUS 14 3.7% 
PROVIDENCIA 1 .3% 
PSEUDOMONAS 60 15.7% 
Total 382 100.0% 
 
 
Table II: Resistance and Senstivity Pattern of 
Cephalosporins  and  their   Association   with 
Bacteria 
In  case  of  Cefixime,  out  of  141  samples,  131   
(92.9%)   were   resistance   while   only   10   (7.1%) 
were   sensitive   (Table   II).   Complete   resistance   
was shown by Enterococcus, Acinetobacter and 
Proteus. 
Isolates  tested  against  Cefotaxime   also   showed  
high  resistance.  218  (93.2%)  isolates  out  of   234  
were resistant while  only  16  (6.8%)  were  found  to  
be sensitive. Complete resistance was shown by 
Acinetobacter, Proteus and Providencia, while 
Escherichia   Coli   and   Coliforms   showed    12.7% 
and 12.5% sensitivity. (Table III) 
Resistance was remarkably high  in  case  of 
Ceftazidime too. Out  of  230  isolates,  193  (83.9%) 
were found to be resistant  while  only  37  (16.1%)  
were  sensitive  (Table  II).  The  drug  showed  
complete resistance against  Acinetobacter, 
Enterococcus and Providencia. However, some 
sensitivity was exhibited by Escherichia Coli,  
Coliforms, Klebsiella, Pseudomonas calculated as 
21.9%,  27.5%,   16.1%   and   22.0%   respectively   
(Table 3).  The  results  were  significant  with  a  P  
value of 0.02 (Table II). 
The resistance and sensitivity patterns against 
Ceftriaxone  showed  that  116   (93.5%)   samples   out 
of 124 were resistant while only 8  (6.5%)  were  
sensitive  (Table   II).   Complete   resistance   was 
shown against Acinetobacter, Proteus, 
Pseudomonas   and   Enterococcus.    Coliforms  
showed  50%  resistance,   while   Escherichia   Coli   
and Klebsiella had 4% and 16.7% sensitivity 
Cephalosporin Resistant Sensitive P-Value 
Cephradine (n=13) 13 (100%) 0 (0.00%) - 
Cefixime (n=141) 131 (92.9%) 10 (7.1%) 0.117 
Cefotaxime (n=234) 218 (93.2%) 16 (6.8%) 0.111 
Ceftazidime (n=230) 193 (83.9%) 37 (16.1%) 0.020 
Ceftriaxone (n=124) 116 (93.5%) 8 (6.5%) 0.002 
Cefepime (n=61) 48 (78.7%) 13 (21.3%) 0.026 
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respectively  (Table  III).  Results   were   significant 
with a P value 0.002 (Table II). 
Out of the 61 isolates which were tested against 
Cefepime, 48 (78.9%) showed resistance while 13 
(21.3%) were found to be sensitive  (Table  II).  
Complete  resistance  was  found  against 
Acinetobacter, Klebsiella and Proteus, while  
Escherichia Coli, Coliforms  and  Pseudomonas  
showed   40.0%,   33.3%   and    28.6%    sensitivity 
(Table  3).  Results  were  significant  with  a  P  value   
of 0.026 (Table II) 
 
Discussion 
Studies to determine  antimicrobial  patterns  of 
different   drugs   are   directed   widely   to   observe 
the  trends  of  antimicrobial  resistance  among 
different  drugs.  In  Islamabad  and  Rawalpindi 
region, Cephalosporins are widely prescribed by 
physicians  as  empirical   therapy   without   culture 
and sensitivity, and have also been used in self- 
medication practices widely.18 Such 
indiscriminate  use  has  led   to   increased 
antimicrobial resistance.19 
Culture   positive   samples   majorly   grew   
Escherichia Coli, Acinetobacter, Klebsiella and 
Coliforms   in   descending   order,    and    majority 
were collected from pus and wounds. This was 
coherent  with  a  similar  study   conducted   in 
Pakistan which had maximum samples having 
Escherichia  Coli  as  the  dominant  pathogen,   
however majorly collected for urine. 20 
A study conducted in Karachi in 2015 showed  
relatively less  resistance  rates  compared  to  our 
study.  For  Ceftriaxone  there  was  67%,  47%,  60% 
and 64% resistance against  Escherichia  Coli,  
Klebsiella, Proteus and Pseudomonas 
respectively  20,  while  a  study  conducted   in 
Peshawar in 2016 also showed 16.2%, 20%, 12.5% 
and 56.3% resistance respectively 21. Results were 
different  in  our  study  conferring  96.2%,  86.3%,  
100% and 100% resistance  for  the  respective 
pathogens against Ceftriaxone. 
Similar   was   the   case   with    Cefotaxime;  
Escherichia Coli,  Klebsiella,  Proteus  and 
Pseudomonas showing 67%, 47%, 60% and 73% 
resistance  20  while   our   study   showed   87.3%,  
94.4%, 100% and 91.7% respectively. 
In case  of  Ceftazidime,  the  resistance  was  32.4%,  
0%,  50%  and  25%   for   Eshcherichia   Coli,   
Klebsiella,  Pseudomonas  and  Proteus  seen   a  
study.21  Our  study   showed   much   higher   
resistance,   conferring   78.1%,   83.9%,   78%   and 
85.6% for the  respective  pathogens  against 
Ceftazdime. 
Adding  further,  similar   results   were   seen   with  
the studies in Karachi and Peshawar in case of 
enterococcus, conferring 100% resistance against 
Cephradine.20-21 
Pseudomonas, Escherichia  Coli  and  Klebsiella  
showed  23.5%,   17.9%   and   42.9%   resistance   
against Cefepime in  a  study  in  Pakistan  by  Nasiri  
MI  in  2013.22  These  results   had   significant  
difference from our study as  Pseudomonas,  
Escherichia  Coli  and  Klebsiella  showed  71.4%,   
60.0%  and  100%  resistance   against   Cefepime.   
Given these results, efficacy  of  Cefepime  against  
these pathogens has become highly questionable. 
 
A  study  conducted  in  Pakistan  by  Begum  S  in   
2013 showed that resistance of Ceftriaxone and 
Ceftazidime   is   100%   against    Acinetobacter.    23 
This is coherent to our study as both these drugs 
showed 100% resistance to  Acinetobacter.  These 
results  were  also  similar  to  recent   studies  
conducted in India 24 and Saudi Arabia  25  which 
showed resistance to Cephaloporins with  
Acinetobacter greater than 98%. 
 
 
BACTERIA 
CEPHRADINE CEFIXIME CEFOTAXIME CEFTAZIDIME CEFTRIAXONE CEFEPIME 
R S R S R S R S R S R S 
Acinetobacter - - 39 
100% 
0 
00.0% 
64 
100% 
0 
00.0% 
54 
100% 
0 
00.0% 
41 
100% 
0 
00.0% 
16 
100% 
0 
00.0% 
Coliforms - - 18 
81.8% 
4 
18.2% 
21 
87.5% 
3 
12.5% 
21 
72.4% 
8 
27.5% 
8 
66.7% 
4 
33.3% 
2 
66.7% 
1 
33.1% 
E. coli - - 29 
93.5% 
2 
6.5% 
55 
87.3% 
8 
12.7% 
50 
78.1% 
14 
21.9% 
25 
96.2% 
1 
3.8% 
15 
60.0% 
10 
40.0% 
Enterococcus 13 
100% 
0 
00.0% 
4 
100% 
0 
00.0% 
- - 3 
100% 
0 
00.0% 
1 
100% 
0 
00.0% 
- - 
Klebsiella - - 16 
84.2% 
3 
15.8% 
34 
94.4% 
2 
5.6% 
26 
83.9% 
5 
16.1% 
19 
86.3% 
3 
13.7% 
9 
100.0% 
0 
00.0% 
Proteus - - 6 
100% 
0 
00.0% 
10 
100% 
0 
00.0% 
6 
85.7% 
1 
14.3% 
7 
100% 
0 
00.0% 
1 
100.0% 
0 
00.0% 
Providencia - - - - 1 
100% 
0 
00.0% 
1 
100% 
0 
00.0% 
- - - - 
Pseudomonas - - 19 
95.0% 
1 
5.0% 
33 
91.7% 
3 
8.3% 
32 
78.0% 
9 
22.0% 
15 
100% 
0 
00.0% 
5 
71.4% 
2 
28.6% 
Table III: Antibiogram of Cephalosporins 
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Compared  to   International   studies   and   analysis, 
the southern Asia region show  much  greater  
resistance  in  terms  of  Cephalosporins   compared 
with Europe,  Americas,  Central  Asia,  however, 
values  were   relatively   close   to   African   and 
Middle  Eastern   Countries.26   This   finding   is 
coherent with our study. 
 
Conclusion 
Based  on  our   research   high   resistance   has 
emerged among 1st, 3rd and 4th generation 
Cephalosporins. Only Cefepime has below 50% 
resistance and that too just with Escherichia Coli. 
However,  resistance  to   Cefepime   is   developing 
very   rapidly.   Indiscriminate   use    of  
Cephalosporins   should   be   curtailed    immediately 
to stop the further progression of resistance. 
Cephalosporins,  however,  can  still  be  used  as  a  
part  of   multidrug   regimens.   Antibiotic 
susceptibility tests should be modified to include 
combinations with other  drugs  and  anti-beta 
lactamase   agents   to   study   the   effects   of 
enhancing  agents  on  the  efficacy   of   
Cephalosporins. 
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